Tag: Bob Wachter
Wie man mit Risiken und Gefährdungen umgeht
Menschen schlängeln sich im Jahr 2022 in einer durch Rungen gebildeten Warteschlange an einem Sicherheitskontrollpunkt am San Francisco International Airport.
Lea Suzuki/The ChronicleDa COVID-19 in der Bay Area und im ganzen Land zunimmt, während die Menschen reisen und sich in den Ferien versammeln, wie sollten Sie in der Zeit nach der Pandemie mit Risiken umgehen und mit Risiken umgehen?
Auch wenn die Einschränkungen im Bereich der öffentlichen Gesundheit längst aufgehoben wurden, gelten laut mindestens einem bekannten Gesundheitsexperten aus der
Biden’s COVID Is Back. Is Paxlovid to Blame?
Four days after recovering from a COVID-19 infection, President Joe Biden has tested positive again. When he first got sick, Biden—like more than one-third of the Americans who have tested positive for COVID-19 this summer, according to the U.S. government’s public records—was prescribed Paxlovid, an antiviral pill treatment made by Pfizer. Like many Paxlovid takers, he soon tested negative and resumed his normal activities. And then, like many Paxlovid takers, his infection came right back. (Biden does not currently have
Rebound COVID Is Just the Start of Paxlovid’s Mysteries
The first data on Paxlovid, out last November, hinted that the COVID antiviral would cut the risk of hospitalization and death by 89 percent. Pundits called the drug “a monster breakthrough,” “miraculous,” and “the biggest advance in the pandemic since the vaccines.” “Today’s news is a real game-changer,” said Albert Bourla, the CEO of Pfizer, which makes the drug. The pills are “a game changer,” President Joe Biden repeated a few months later.
Now, finally, the game is being changed.